Champix warnings and precautions

  • Clinicians should be aware of the possible emergence of serious neuropsychiatric symptoms in patients attempting to quit smoking with or without treatment.
  • If serious neuropsychiatric symptoms occur whilst on varenicline treatment, patients should discontinue varenicline immediately and contact a healthcare professional for re-evaluation of treatment.
  • Care should be taken with patients with a history of psychiatric illness and patients should be advised accordingly.
  • CHAMPIX should be used cautiously in patients with a history of seizures or other conditions that potentially lower the seizure threshold.

Please refer to the summary of product characteristics for further information on the safety profile of Champix

PP-CHM-GBR-2954.  August 2019